1. Home
  2. BIIB vs CTSH Comparison

BIIB vs CTSH Comparison

Compare BIIB & CTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biogen Inc.

BIIB

Biogen Inc.

N/A

Current Price

$249.28

Market Cap

34.5B

Sector

Health Care

ML Signal

N/A

Logo Cognizant Technology Solutions Corporation

CTSH

Cognizant Technology Solutions Corporation

N/A

Current Price

$58.52

Market Cap

31.8B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BIIB
CTSH
Founded
1978
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
34.5B
31.8B
IPO Year
1996
1998

Fundamental Metrics

Financial Performance
Metric
BIIB
CTSH
Price
$249.28
$58.52
Analyst Decision
Buy
Buy
Analyst Count
36
29
Target Price
★ $268.26
$69.42
AVG Volume (30 Days)
1.1M
★ 5.6M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
N/A
★ 2.20%
EPS Growth
N/A
★ 1.11
EPS
2.66
★ 4.14
Revenue
$9,890,600,000.00
★ $21,108,000,000.00
Revenue This Year
$6.92
$4.72
Revenue Next Year
$1.91
$3.97
P/E Ratio
$94.29
★ $14.49
Revenue Growth
2.22
★ 6.95
52 Week Low
$160.36
$37.08
52 Week High
$261.00
$87.03

Technical Indicators

Market Signals
Indicator
BIIB
CTSH
Relative Strength Index (RSI) 54.04 37.11
Support Level $240.00 $56.40
Resistance Level $259.89 $63.79
Average True Range (ATR) 7.29 2.02
MACD -1.09 -0.90
Stochastic Oscillator 43.79 0.00

Price Performance

Historical Comparison
BIIB
CTSH

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

About CTSH Cognizant Technology Solutions Corporation

Cognizant Technology Solutions is a multinational IT services provider that offers a range of consulting and business process outsourcing services. Originally founded in India, the company is headquartered in the US and serves enterprise customers spanning the financial services, healthcare, and resources industries. With most of its workforce located in India, Cognizant leverages a global delivery model that helps clients outsource their IT needs to offshore labor.

Share on Social Networks: